HYS-32, a novel analogue of combretastatin A-4, enhances connexin43 expression and gap junction intercellular communication in rat astrocytes

Keyphrases

• 2(5H)-furanone 16%
• Antitumor Compounds 16%
• Astrocytes 83%
• Biological Effects 16%
• Central Nervous System 16%
• Cis-stilbene 16%
• Co-treatment 50%
• Combretastatin A4 Phosphate (CA4P) 100%
• Connexin 43 (Cx43) 100%
• Cx43 Expression 50%
• Cx43 Gap Junctions 16%
• Cycloheximide 16%
• Dye Transfer 16%
• ERK Inhibitor 16%
• ERK Pathway 16%
• Gap Junction 16%
• Gap Junction Intercellular Communication 100%
• Gap Junction Plaques 33%
• Gö6976 33%
• Induced Activation 16%
• JNK Inhibitor 16%
• LPS-induced Inflammation 16%
• Microscopic Study 16%
• Microtubules 33%
• New Analogs 16%
• Novel Analogues 100%
• PD98059 33%
• Phospho-ERK 16%
• PKC Inhibitor 16%
• PKC Phosphorylation 16%
• Primary Astrocytes 16%
• Protective Agents 16%
• Rat Astrocytes 100%
• Scrape Loading 16%
• Signaling Cascades 16%
• Signaling Pathway 16%
• SP600125 16%
• Therapeutic Use 16%
• Time-dependent Degradation 16%
• Transfer Component Analysis 16%
• Western Blot Analysis 16%

Pharmacology, Toxicology and Pharmaceutical Science

• 2 (2 Amino 3 Methoxyphenyl)chromone 100%
• anthra[1,9 Cd]pyrazol 6(2h) One 50%
• Combretastatin A4 100%
• Cycloheximide 50%
• Neoplasm 50%
• Protective Agent 50%
• Stilbene 50%
• Stress Activated Protein Kinase Inhibitor 50%
• Therapeutic Use 50%
• Western Blot 50%